125 related articles for article (PubMed ID: 37852646)
1. How to Obtain Perfect Positioning for Renal Flow Scintigraphy Using
Deimer D
J Nucl Med Technol; 2024 Jun; 52(2):102-103. PubMed ID: 37852646
[No Abstract] [Full Text] [Related]
2. An incidental detection of aortic aneurysm on Tc-99m MAG3 renal scintigraphy.
Sadic M; Demirel K; Koca G; Atilgan HI; Korkmaz M
Nucl Med Rev Cent East Eur; 2013; 16(2):97-9. PubMed ID: 24068642
[TBL] [Abstract][Full Text] [Related]
3. Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy.
Mukai T; Sato S; Iguchi T; Mimura H; Yasui K; Gobara H; Saika T; Nasu Y; Kumon H; Kanazawa S
Acta Med Okayama; 2006 Apr; 60(2):85-91. PubMed ID: 16680184
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m MAG3 renal scintigraphy with demonstration of aortic dissection.
Nguyen BD
Clin Nucl Med; 2005 Aug; 30(8):586-7. PubMed ID: 16024966
[TBL] [Abstract][Full Text] [Related]
5. Superiority of tc-99m MAG3 to tc-99m DTPA in treating a patient with mild renal artery stenosis.
Kiratli PO; Caner B; Altun B; Cekirge S
Ann Nucl Med; 2001 Feb; 15(1):45-8. PubMed ID: 11355781
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m DMSA and Tc-99m MAG3 findings in crossed renal ectopia.
Jiménez-Heffernan A; Rebollo AC; Garcia-Martin M; Herrera C; Acosta J
Clin Nucl Med; 1998 Apr; 23(4):255. PubMed ID: 9554207
[No Abstract] [Full Text] [Related]
7. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-mercaptoacetyltriglycine camera-based measurement of renal clearance: should the result be normalized for body surface area?
Klingensmith WC
J Nucl Med Technol; 2013 Dec; 41(4):279-82. PubMed ID: 24167023
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
[TBL] [Abstract][Full Text] [Related]
10. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
11. Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Werner RA; Bluemel C; Lapa C; Muegge DO; Kudlich T; Buck AK; Herrmann K
Nucl Med Commun; 2014 Nov; 35(11):1143-9. PubMed ID: 25171439
[TBL] [Abstract][Full Text] [Related]
12. Renal nuclear medicine: a review.
Daniel GB; Mitchell SK; Mawby D; Sackman JE; Schmidt D
Vet Radiol Ultrasound; 1999; 40(6):572-87. PubMed ID: 10608684
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of a single vial lyophilized preparation of technetium-99m labeled ethylene dicysteine as a renal scintigraphic agent.
Sohaib M; Afshan A; Saeed S; Khalid MA; Yousuf M
Pak J Pharm Sci; 2014 Sep; 27(5):1287-94. PubMed ID: 25176364
[TBL] [Abstract][Full Text] [Related]
14. Renal clearance of technetium-99m-MAG3: normal values.
Russell CD; Li Y; Nadiye Kahraman H; Dubovsky EV
J Nucl Med; 1995 Apr; 36(4):706-8. PubMed ID: 7699471
[No Abstract] [Full Text] [Related]
15. Is there still a need for Tc-99m DMSA renal imaging?
Bair HJ; Becker W; Schott G; Kühn RH; Wolf F
Clin Nucl Med; 1995 Jan; 20(1):18-21. PubMed ID: 7895429
[TBL] [Abstract][Full Text] [Related]
16. Left abdominal uptake of Tc-99m MAG3 on renal imaging.
Bekiş R; Durak H; Oner B
Clin Nucl Med; 1998 Nov; 23(11):777-8. PubMed ID: 9814571
[No Abstract] [Full Text] [Related]
17. A comparative study of renal scintigraphy and clearance with 99mTc-MAG3 and 123I-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
Contrib Nephrol; 1990; 79():32-5. PubMed ID: 2146087
[No Abstract] [Full Text] [Related]
18. Vicarious excretion of technetium-99m MAG3 in a patient with polycystic renal disease.
Wulfeck DW; Sakow NK; Senler SO
Clin Nucl Med; 1993 Mar; 18(3):239-40. PubMed ID: 8462218
[No Abstract] [Full Text] [Related]
19. Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.
Melis M; de Swart J; de Visser M; Berndsen SC; Koelewijn S; Valkema R; Boerman OC; Krenning EP; de Jong M
J Nucl Med; 2010 Dec; 51(12):1962-8. PubMed ID: 21078795
[TBL] [Abstract][Full Text] [Related]
20. [Follow-up after kidney transplantation. Sequential functional scintigraphy with technetium-99m-DTPA or technetium-99m-MAG3].
Kramer W; Baum RP; Scheuermann E; Hör G; Jonas D
Urologe A; 1993 Mar; 32(2):115-20. PubMed ID: 8475609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
